KeViRx is a biotechnology company that develops therapeutics for cancer and respiratory disorders.
KeViRX's investors include U.S. Department of War, Activation Capital.
KeViRX is headquartered in Charlottesville, United States.
KeViRx is a biotechnology company that develops therapeutics for cancer and respiratory disorders.
KeViRX is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KeViRX — Funding & Investors." VCBacked, October 28, 2024, https://www.vcbacked.co/company/kevirx. Accessed August 15, 2026.
VCBacked. (2024). KeViRX — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/kevirx
{{cite web |title=KeViRX — Funding & Investors |url=https://www.vcbacked.co/company/kevirx |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated